Europe • Frankfurt Stock Exchange • FRA:7V0 • DE000A3C35W0
The current stock price of 7V0.DE is 11.6 EUR. In the past month the price increased by 43.21%. In the past year, price decreased by -57.04%.
ChartMill assigns a technical rating of 4 / 10 to 7V0.DE. When comparing the yearly performance of all stocks, 7V0.DE is a bad performer in the overall market: 70.73% of all stocks are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
null analysts have analysed 7V0.DE and the average price target is 22.44 EUR. This implies a price increase of 93.45% is expected in the next year compared to the current price of 11.6.
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ARGX | ARGENX SE | 28.07 | 43.368B | ||
| 1AE | ARGENX SE | 27.78 | 43.306B | ||
| 22UA | BIONTECH SE-ADR | N/A | 22.074B | ||
| ABVX | ABIVAX SA | N/A | 7.703B | ||
| 2X1 | ABIVAX SA | N/A | 7.695B | ||
| GXE | GALAPAGOS NV | N/A | 1.887B | ||
| GLPG | GALAPAGOS NV | N/A | 1.871B | ||
| IVA | INVENTIVA SA | N/A | 984.579M | ||
| 6IV | INVENTIVA SA | N/A | 978.821M | ||
| NANO | NANOBIOTIX | N/A | 972.597M |
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
Darwin AG engages in the analysis of genetic materials and provides related research and development, as well as consulting services. The company is headquartered in Muenchen, Bayern. The company went IPO on 2021-11-02. The firm develops and sells and dietary supplements and cosmetics products. The company uses advances in Biotechnology and AI to create personalized solutions based on scientific lab analysis data. The company has fully licensed laboratories cover the whole range of genetic and metabolomic testing, ranging from lifestyle personal genomics to embryo screening during IVF to improve success rates.
DARWIN AG
Brienner Strasse 7, c/o GCI Management Consulting GmbH
Muenchen BAYERN DE
Employees: 235
Phone: 4920500450
Darwin AG engages in the analysis of genetic materials and provides related research and development, as well as consulting services. The company is headquartered in Muenchen, Bayern. The company went IPO on 2021-11-02. The firm develops and sells and dietary supplements and cosmetics products. The company uses advances in Biotechnology and AI to create personalized solutions based on scientific lab analysis data. The company has fully licensed laboratories cover the whole range of genetic and metabolomic testing, ranging from lifestyle personal genomics to embryo screening during IVF to improve success rates.
The current stock price of 7V0.DE is 11.6 EUR. The price increased by 1.75% in the last trading session.
DARWIN AG (7V0.DE) has a dividend yield of 4.89%. The yearly dividend amount is currently 0.
7V0.DE has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
DARWIN AG (7V0.DE) has a market capitalization of 139.20M EUR. This makes 7V0.DE a Micro Cap stock.
You can find the ownership structure of DARWIN AG (7V0.DE) on the Ownership tab.